
Discovery delays 2026 contribution increase to April
Leading open medical schemes have announced increases above the CMS’s guidance, underscoring the tension between regulator calls for restraint and schemes’ funding needs.

Leading open medical schemes have announced increases above the CMS’s guidance, underscoring the tension between regulator calls for restraint and schemes’ funding needs.

The curator will assess Sizwe Hosmed’s finances and recommend whether it should merge, be liquidated, or continue.

The Council for Medical Schemes recommends capping 2026 contribution increases at 3.3% plus “reasonable utilisation estimates”, yet past trends show schemes often push far higher.

Statistical analysis found that black healthcare professionals were multiple times more likely than their white peers to be investigated and found guilty of FWA.

Medihelp says its recovery plan is on track, with strong cost controls, younger members, and CMS-approved funding measures set to restore financial stability by 2026.

A significant ruling by the Appeal Board rendered the processes outlined in the circulars published in 2022 invalid.

The Board of Healthcare Funders says it will appeal after the High Court dismissed its application on procedural and substantive grounds.

Insurers are allowed to offer primary healthcare policies for an additional two years pending the finalisation of a framework for low-cost benefit options.

The Competition Tribunal has dismissed key objections from major pathology laboratories, moving the medical schemes closer to having their damages claim heard in the High Court.

After months of speculation, Sanlam has officially partnered with Fedhealth as its exclusive open medical scheme provider.

In its long-awaited report, the Council for Medical Schemes says its preferred recommendation is not to introduce LCBOs.

The Board of Healthcare Funders questions the timing and content of the CMS’s report, claiming it ignores stakeholder input and the opposition to low-cost benefit options is politically motivated.

The Board of Health Funders has ‘serious reservations’ about giving the Department of Health the power to manage the block exemption negotiation process.

A regulatory expert believes the judgment misinterpreted key legal principles in its ruling on the RAF’s obligation to reimburse medical schemes.

The case raises questions about whether LCBOs will expand access to affordable private healthcare or threaten the rollout of NHI.

Dr Musa Gumede steps into the role of Registrar of the CMS, succeeding Dr Sipho Kabane, whose tenure was marked by significant challenges and critical industry reforms.

Bestmed states pending rules for low-cost benefit options have further complicated efforts to reduce costs for members.